Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|236|3|278-289

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.236, Iss.3, 2015-07, pp. : 278-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 7, 2015-10 ,pp. : 1587-1597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice

By  

THE PROSTATE, Vol. 75, Iss. 6, 2015-05 ,pp. : 593-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components

By  

THE PROSTATE, Vol. 78, Iss. 5, 2018-04 ,pp. : 343-352

John Wiley & Sons Inc

Access to resources Recommend Favorite

Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cells

By  

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1281-1290

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting

By Jain Amit   Gulbake Arvind   Jain Ashish   Shilpi Satish   Hurkat Pooja   Jain Aviral   Jain Sanjay K.  

Journal of Microencapsulation, Vol. 29, Iss. 1, 2012-01 ,pp. : 95-102

Informa Healthcare

Access to resources Recommend Favorite